Skip to content

Effect of diazepam, ketamine and pethidine on retrograde amnesia after general anesthesia

Effect of diazepam, ketamine and pethidine on retrograde amnesia after general anesthesia

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT201104106164N1
Enrollment
150
Registered
2011-05-18
Start date
2010-09-26
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retrograde amnesia for unpleasant events in the perioperative period. Reaction to severe stress, and adjustment disorders

Interventions

Intervention 1: Control group: There are 50 patients in control group that receive placebo (water) intravenously. Drugs or placebo are prepared in identical syringes and are randomly administered dur
Placebo
Treatment - Drugs
Control group: There are 50 patients in control group that receive placebo (water) intravenously. Drugs or placebo are prepared in identical syringes and are randomly administered during a period of
Intervention group 1: In the recovery room, immediately after visual, sensory and auditory stimuli, the first intervention group (50 patients) receive intravenous ketamine 0.3 mg/kg in addition to di
Intervention group 2: In the recovery room, immediately after visual, sensory and auditory stimuli, the second intervention group (50 patients) receive intravenous ketamine 0.5 mg/kg in addition to d

Sponsors

Ahvaz Judishapur university of medical sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 35 Years

Inclusion criteria

Inclusion criteria: Patients aged 18 to 35 years (ASA CLASS I) undergoing surgery and general anesthesia are included in this study. Patients that should not receive ketamine because of intracranial mass, increased intracranial pressure, head trauma, open globe injuries, ischemic heart disease, vascular aneurisms, psychological disorders, and history of adverse reactions to ketamine are excluded from this study.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Recall of the sensory stimuli. Timepoint: Before administration of drugs or placebo in the postanesthesia care unit (PACU), before discharge from PACU and also 10 hours after discharge. Method of measurement: Questionnaire.;Recall of the visual stimuli. Timepoint: Before administration of drugs or placebo in the postanesthesia care unit (PACU), before discharge from PACU and also 10 hours after discharge. Method of measurement: Questionnaire.;Recall of the auditory stimuli. Timepoint: Before administration of drugs or placebo in the postanesthesia care unit (PACU), before discharge from PACU and also 10 hours after discharge. Method of measurement: Questionnaire.;Recall of the surgery day events. Timepoint: Before administration of drugs or placebo in the postanesthesia care unit (PACU), before discharge from PACU and also 10 hours after discharge. Method of measurement: Questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactEhsan Farazi

Ahvaz Judishapur university of medical sciences

farazi.e@ajums.ac.ir+98 61 1374 3037

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026